Renephra

About:

Developing novel technology for treatment of fluid overload and chronic oedema, grounded in world-class research and clinical excellence.

Website: http://renephra.com/

Twitter/X: renephra

Top Investors: Innovate UK, Deepbridge Capital, NorthInvest, Catapult Ventures, SBRI Healthcare

Description:

Renephra Ltd is a medical device company developing a groundbreaking Transdermal Fluid Removal (TFR) technology for minimally invasive fluid removal. We are targeting the significant problems of fluid overload and chronic oedema / lymphoedema in vascular, oncology and other disease areas. This is a substantial patient group with unmet clinical needs and is an estimated £1billion market worldwide. Having achieved proof of concept in humans, Renephra is raising £400k to conduct device development study and design feasability.